Gülseren Aras Selected Research

Thyroglobulin

10/2008	The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
12/2007	Is thyroglobulin the stronger indicator for progressive disease than the other conventional factors in same age patient groups with differentiated thyroid cancer?
07/2006	Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results.
03/2006	Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.

5	Thyroid Neoplasms (Thyroid Cancer) 10/2008 - 03/2006
1	Sarcoidosis (Schaumann Disease) 12/2007
1	Neoplasm Metastasis (Metastasis) 03/2006

4	Thyroglobulin FDA Link 10/2008 - 03/2006
2	anti-thyroglobulinIBA 10/2008 - 11/2006
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2007
1	AntibodiesIBA 11/2006